drug induced obesity. Use additional external cause code (Chapter XX), if desired, to identify drug.
Conditions
Interventions
Intervention 1: Drug group:pearl 50000 unit, vitamin D3,that every 2 week prescribe to 12 week. Intervention 2: Control : placebo of vitamin D3,that every 2 week prescribe to 12 week.
Treatment - Drugs
Drug group:pearl 50000 unit, vitamin D3,that every 2 week prescribe to 12 week
Control : placebo of vitamin D3,that every 2 week prescribe to 12 week.
Sponsors
Ahvaz Unversity Of Medical Science
Eligibility
Sex/Gender
Female
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:women with psychiatric disorder;20-55 years old;not pregnant;have not any medical illness;during consuming olanzapin have weight gain;her serum level of vitamin is normal range. Exclusion criteria:women with medical illness;poly cystic ovarian and women that receive other drug that induced obesity.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight,BMI,Wrist,Hip,Wrist hip ratio. Timepoint: Befor and after intervention. Method of measurement: Befor and after intervention with Scales and meters. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nusea,Headache. Timepoint: Befor intervention. Method of measurement: During intervention repeatedly. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKaviyani Somayeh
Ahvaz University Of Medical Science
Outcome results
None listed